The Rationale: Last Reported Quarter and Management Outlook for 22nd Century Group, Inc. (NASDAQ:XXII)
The Rationale: Last Reported Quarter and Management Outlook for Karyopharm Therapeutics Inc. (NASDAQ:KPTI)
In the quarter ended June 30, 2026, reported on August 17, 2026,Gross Profitrose to USD 1,120,341 from USD 968,095. The operating loss widened to USD 1,320,398 from USD 155,437 and the net loss to USD 2,630,548 from USD 226,056, or USD 0.06 per share …
The second quarter report, filed on August 19, 2026, showed net revenue of USD 1.01 million against USD 1.25 million a year earlier, driven by lower consumer supplement sales. Gross margin was 22.4% versus 58.9%, which the company tied to product mix. General and …
The Rationale: Last Reported Quarter and Management Outlook for Direct Digital Holdings, Inc. (NASDAQ:DRCT)
The Rationale: Last Reported Quarter and Management Outlook for Sangamo Therapeutics, Inc. (OTCQB:SGMO)
Key Highlights28.5 is the USD million of net YARTEMLEARevenueOmeros Corporation (NASDAQ:OMER) reported for the second quarter of 2026, compared with USD 9.9 million in the first quarter, its first full launch quarter.461.2 is the USD million of cash, cash equivalents and investments Jade Biosciences, …
Key Highlights156.3 is the USD million of cash, cash equivalents and marketable securities Larimar Therapeutics, Inc. (NASDAQ:LRMR) held on June 30, 2026, which management projects will fund operations into the third quarter of 2027.13.9 is the USD million net loss Prelude Therapeutics (NASDAQ:PRLD) reported …
Key Highlights14.3 is the USD million of PEMGARDA net productRevenueInvivyd, Inc. (NASDAQ:IVVD) reported for the second quarter of 2026, up from USD 11.8 million, alongside a net loss of USD 44.4 million.61.4 is the USD million of cash, cash equivalents and marketable securities Unicycive …
Key Highlights8.576 is the USD million net operating loss OS Therapies (NYSEAMERICAN:OSTX) reported for the second quarter of 2026, up 77.2%, calculated, from USD 4.839 million a year earlier, with 2.5-year overall survival of 75% versus 47%.73.9 is the USD million of cash and …